Smith & Nephew (MEX:SN1 N) FFO


MEX:SN1 N Smith & Nephew PLC MEX:SN1 N
86 GF Score
Price MXN256.55
GF Value MXN267.48
! 3 Warning Signs
View Full Analysis

What is Smith & Nephew FFO?

FFO (Funds from operations) only applies to REITs.

MEX:SN1 N
86GF Score
Smith & Nephew PLC MEX:SN1 N
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Smith & Nephew (MEX:SN1 N) Overvalued in 2026?

Based on GuruFocus' analysis, Smith & Nephew stock appears to be undervalued. The current stock price of MXN256.55 is trading 4.1% below its estimated GF Value™ of MXN267.48.

Key valuation signals for MEX:SN1 N:

  • FFO:
  • GF Value™: MXN267.48 vs. price of MXN256.55 (4.1% below fair value)
  • GF Score™: 86/100 with 3 warning signs

No single metric tells the full story. See the MEX:SN1 N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Smith & Nephew Business Description

Address Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
86GF Score

Get the complete analysis for MEX:SN1 N

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN256.55
Price
MXN267.48
GF Value